PAT-048 T16434
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
PAT-048 is an effective and selective autotaxin inhibitor. PAT-048 reduces dermal fibrosis in vivo. PAT-048 also inhibits IL-6 mRNA expression but displays no effect on autotaxin protein and pulmonary lysophosphatidic acid (LPA) production in the lung fib
CAS nr:
1359983-15-5
Purity:
98%
Molecular Weight:
461,91
SMILES:
CCCN1N=CC(N2C3=C(C(SC4=CC=CC(C(O)=O)=C4F)=C2C)C=CC(Cl)=C3F)=C1
Formula:
C22H18ClF2N3O2S
Pathway:
Metabolism
Target:
PDE
